MX2015013160A - Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos. - Google Patents

Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos.

Info

Publication number
MX2015013160A
MX2015013160A MX2015013160A MX2015013160A MX2015013160A MX 2015013160 A MX2015013160 A MX 2015013160A MX 2015013160 A MX2015013160 A MX 2015013160A MX 2015013160 A MX2015013160 A MX 2015013160A MX 2015013160 A MX2015013160 A MX 2015013160A
Authority
MX
Mexico
Prior art keywords
drug
dietary supplement
cellular uptake
products
dietary supplements
Prior art date
Application number
MX2015013160A
Other languages
English (en)
Inventor
Daryl L Barnett
Original Assignee
Cba Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cba Pharma Inc filed Critical Cba Pharma Inc
Publication of MX2015013160A publication Critical patent/MX2015013160A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Se describe el mejoramiento de la absorción celular de un fármaco o un suplemento dietético al administrarlo concurrentemente con uno o más miembros de la familia de la d-tetrandrina.
MX2015013160A 2013-03-15 2014-03-12 Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos. MX2015013160A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793028P 2013-03-15 2013-03-15
PCT/US2014/024649 WO2014150959A2 (en) 2013-03-15 2014-03-12 Method and products for enhancing cellular uptake of drug and dietary supplements

Publications (1)

Publication Number Publication Date
MX2015013160A true MX2015013160A (es) 2016-04-04

Family

ID=51529978

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015013160A MX2015013160A (es) 2013-03-15 2014-03-12 Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos.

Country Status (7)

Country Link
US (1) US9254323B2 (es)
EP (1) EP3038655A4 (es)
JP (1) JP2016514143A (es)
KR (1) KR20150141970A (es)
CN (1) CN105377259A (es)
MX (1) MX2015013160A (es)
WO (1) WO2014150959A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015013158A (es) * 2013-03-15 2016-04-15 Cba Pharma Inc Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911454B1 (en) * 1989-09-28 2005-06-28 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant disease
US5332747A (en) 1989-09-28 1994-07-26 Cancer Biologics Of America, Inc. Method for potentiating primary drugs in treating multidrug resistant parasitic disease cells
EP0580790B1 (en) * 1991-04-19 2002-06-26 Cba International, Inc Method for potentiating primary drugs in treating multidrug resistant cells
US6086915A (en) 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US6350476B1 (en) 2000-05-22 2002-02-26 Shanxi Zhengzhon Pharmaceutical Co., Ltd. Herbal chinese joint complex
CN102600159A (zh) * 2012-03-09 2012-07-25 深圳松乐生物科技有限公司 含有粉防己碱及粉防己碱类衍生物和氟喹诺酮类药物的组合物及其应用
WO2014043347A1 (en) * 2012-09-13 2014-03-20 Cba Pharma, Inc. Mdr method and products for treating mrsa
MX2015013158A (es) * 2013-03-15 2016-04-15 Cba Pharma Inc Metodo y productos para mejorar la biodisponibilidad de los farmacos y de los suplementos dieteticos.

Also Published As

Publication number Publication date
EP3038655A2 (en) 2016-07-06
KR20150141970A (ko) 2015-12-21
CN105377259A (zh) 2016-03-02
WO2014150959A2 (en) 2014-09-25
WO2014150959A3 (en) 2015-01-22
US20140275157A1 (en) 2014-09-18
EP3038655A4 (en) 2017-01-18
JP2016514143A (ja) 2016-05-19
US9254323B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
PH12016502132A1 (en) Aryl-or heteroaryl-substituted benzene compounds
MX338515B (es) Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio.
MX2015000813A (es) Composiciones liposómicas de inhibidores de proteasoma basadas en epoxicetona.
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
MX2015012034A (es) El péptido mots3 derivado de mitocondrias regula el metabolismo y supervivencia celular.
UA112288C2 (uk) Склад антитіла, що специфічно зв'язує рецептор а іl-17, і терапевтичні режими
GB2502032A (en) Vitamin D composition
IN2015DN03322A (es)
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
MX347734B (es) Anticuerpos anti-s100a4 y usos aplicaciones terapéuticas.
EP4360621A3 (en) Formulations of bendamustine
IN2014DN06104A (es)
MX2013009007A (es) Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.
GB2492680A (en) Oral supplement
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MX2016006544A (es) Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas.
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
MX2021003908A (es) Polipeptidos de accion prolongada y metodos para su produccion y administracion.
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
MX2015013160A (es) Metodo y productos para mejorar la absorcion celular de farmaco y suplementos dieteticos.
IN2014DN10134A (es)
IN2013CH04898A (es)
UA100942C2 (ru) Лекарственное средство из пчелиных и растительных продуктов
MY184940A (en) Lignosus rhinocerus (tiger-milk mushroom) as anti-inflammatory agent
LV14461A (lv) Līdzeklis efektīvai augsta glutamāta līmeņa pazemināšanai asinīs